All Stories

  1. Vascular endothelial growth factor isoforms differentially protect neurons against neurotoxic events associated with Alzheimer’s disease
  2. When Differential Descending Control of Speed Matters: Descending Modulation of A- versus C-Fiber Evoked Spinal Nociception
  3. Hypoxia induced carbonic anhydrase mediated dorsal horn neuron activation and induction of neuropathic pain
  4. The partial saphenous nerve injury model of pain impairs reward-related learning but not reward sensitivity or motivation
  5. Repeated exposure of naïve and peripheral nerve-injured mice to a snake as an experimental model of post-traumatic stress disorder and its co-morbidity with neuropathic pain
  6. Lamina‐specific population encoding of cutaneous signals in the spinal dorsal horn using multi‐electrode arrays
  7. Diabetes-induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain
  8. Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators
  9. The physiological functions of central nervous system pericytes and a potential role in pain
  10. Targeting a molecule on blood vessels stopped pain spreading in a model of rheumatoid arthritis
  11. Sensory neuronal sensitisation occurs through HMGB-1/ RAGE and TRPV1 in high glucose conditions
  12. Top-down control of pain
  13. Vascular endothelial growth factor-A165b ameliorates outer-retinal barrier and vascular dysfunction in the diabetic retina
  14. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo
  15. Pharmacology of Modulators of Alternative Splicing
  16. The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain
  17. Alternative RNA splicing: contribution to pain and potential therapeutic strategy
  18. Periaqueductal Grey EP3 Receptors Facilitate Spinal Nociception in Arthritic Secondary Hypersensitivity
  19. Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration
  20. A novel method for delivering ramped cooling reveals rat behaviours at innocuous and noxious temperatures: A comparative study of human psychophysics and rat behaviour
  21. Differential contributions of A- and C-nociceptors to primary and secondary inflammatory hypersensitivity in the rat
  22. Intrathecal reboxetine suppresses evoked and ongoing neuropathic pain behaviours by restoring spinal noradrenergic inhibitory tone
  23. Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy
  24. Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia
  25. Periaqueductal grey cyclooxygenase‐dependent facilitation of C‐nociceptive drive and encoding in dorsal horn neurons in the rat
  26. The degree of acute descending control of spinal nociception in an area of primary hyperalgesia is dependent on the peripheral domain of afferent input
  27. VEGF-A165b Is an Endogenous Neuroprotective Splice Isoform of Vascular Endothelial Growth Factor A in Vivo and in Vitro
  28. Single bright light exposure decreases sweet taste threshold in healthy volunteers
  29. Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects
  30. Arthritis Model, Adjuvant-Induced Arthritis
  31. SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases
  32. Spontaneous firing in C-fibers and increased mechanical sensitivity in A-fibers of knee joint-associated mechanoreceptive primary afferent neurones during MIA-induced osteoarthritis in the rat
  33. Peripheral Galanin Receptor 2 as a Target for the Modulation of Pain
  34. Ovarian VEGF165b expression regulates follicular development, corpus luteum function and fertility
  35. Differential Roles of Galanin on Mechanical and Cooling Responses at the Primary Afferent Nociceptor
  36. Piperazine-2,3-dicarboxylic Acid Derivatives as Dual Antagonists of NMDA and GluK1-Containing Kainate Receptors
  37. Taste perception and implicit attitude toward sweet related to body mass index and soft drink supplementation
  38. Activation of the Galanin Receptor 2 in the Periphery Reverses Nerve Injury-Induced Allodynia
  39. Intact cutaneous C fibre afferent properties in mechanical and cold neuropathic allodynia
  40. Transient receptor potential channel A1 and noxious cold responses in rat cutaneous nociceptors
  41. Taste and weight: is there a link?
  42. Effects of acute abstinence and nicotine administration on taste perception in cigarette smokers
  43. Neurogenic Mechanisms in Arthritis
  44. Inflammation reduces mechanical thresholds in a population of transient receptor potential channel A1-expressing nociceptors in the rat
  45. Characterization of a novel neuropathic pain model in mice
  46. Peripheral cannabinoid CB1 receptors inhibit evoked responses of nociceptive neurones in vivo
  47. C‐terminal splice variants of the μ‐opioid receptor: existence, distribution and functional characteristics
  48. Cyclooxygenase-1-Derived Prostaglandins in the Periaqueductal Gray Differentially Control C- versus A-Fiber-Evoked Spinal Nociception
  49. Sensory nerves have altered function contralateral to a monoarthritis and may contribute to the symmetrical spread of inflammation
  50. Human Taste Thresholds Are Modulated by Serotonin and Noradrenaline
  51. Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice
  52. Understanding pulpitis
  53. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term
  54. Inflammation alters somatostatin mRNA expression in sensory neurons in the rat
  55. Inflammation alters cation chloride cotransporter expression in sensory neurons
  56. A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation
  57. Sensory neuropeptide mRNA up-regulation is bilateral in periodontitis in the rat: a possible neurogenic component to symmetrical periodontal disease
  58. Characterisation of a Freund's complete adjuvant-induced model of chronic arthritis in mice
  59. Identification of a prostaglandin E2 receptor splice variant and its expression in rat tissues
  60. Expression and regulation of prostaglandin E receptor subtype mRNAs in rat sensory ganglia and spinal cord in response to peripheral inflammation
  61. Cyclooxygenase-1 is a marker for a subpopulation of putative nociceptive neurons in rat dorsal root ganglia
  62. Specific Testicular Cellular Localization and Hormonal Regulation of the PKIα and PKIβ Isoforms of the Inhibitor Protein of the cAMP-dependent Protein Kinase
  63. Inducible receptors
  64. Functional characterization by heterologous expression of a novel cloned tachykinin peptide receptor
  65. Molecular Characterization of a Putative K-Cl Cotransporter in Rat Brain
  66. Induction of transcription factor AP2 mRNA expression in rat primary afferent neurons during acute inflammation
  67. Neuropeptide gene expression and capsaicin-sensitive primary afferents: maintenance and spread of adjuvant arthritis in the rat.
  68. Transcription factor AP-2 gene expression in adult rat hippocampal regions: effects of environmental manipualtions
  69. Endogenous Glucocorticoids and the Induction and Spread of Monoarthritis in the Rat
  70. Local anaesthesia prevents acute inflammatory changes in neuropeptide messenger RNA expression in rat dorsal root ganglia neurons
  71. Glucocorticoid receptor and NGFI-A gene expression are induced in the hippocampus after environmental enrichment in adult rats
  72. A discrete adjuvant-induced monoarthritis in the rat: effects of adjuvant dose
  73. Increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal peptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat
  74. Arthritis Model, Adjuvant-Induced Arthritis